Delivery Order SPE2DR25D1022-SPE2DR26FQV2B
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials, with performance scheduled for completion by November 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $98,923.44 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This competitively awarded, firm fixed-price contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services to the federal government under its existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,101.19 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by February 4, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems....
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $14,408.16 by the Defense Logistics Agency (DLA) for the supply of Xeomin 200 Unit Vials, with a completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,003.40 by the Defense Logistics Agency (DLA) on January 5, 2026, for the supply of Xeomin 100 Unit Vials. The award uses firm fixed-price pricing and carries an ultimate completion date of January 27, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which...
- The Defense Logistics Agency awarded a $19,569.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 3, 2025, for the supply of Xeomin 100 Unit Vials, with completion required by January 27, 2025. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,057.32 by the Defense Logistics Agency on June 2, 2025, for the supply of Xeomin 100 unit vials, with completion scheduled for June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,214.28 for Xeomin 100 Unit Vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract represents a non-competitive delivery order issued without set-aside designation to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $11,733.54 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials, with a completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor to the federal government,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Xeomin 200 Unit Vials, with a ceiling value of $74,192.16 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by January 13, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQV2BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $75.6K to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. This is a firm fixed-price, non-set-aside contract with a completion date of February 12, 2026, and represents a single delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. This prime IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The award reflects the company's capability to meet federal procurement requirements through open competition and deliver essential medical commodities efficiently across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.6k | 1/21/26 |